<qa>  What was the G20210A gene mutation?In September 2006, GTC Biotherapeutics modified exclusion criteria 1 below to allow for the participation of previously excluded patients with the hereditary thrombophilic disorders Factor V Leiden and prothrombin gene mutation G20210A. 